Activation of volume regulated chloride channels (VRCCs) has been shown to be cardioprotective in ischemic preconditioning (IPC) of isolated hearts but the underlying molecular mechanisms remain unclear. Recent independent studies support that ClC-3, a ClC voltage-gated chloride channel, may function as a key component of the VRCCs. Thus, ClC-3 knockout (Clcn3 -/-
) mice and their age-matched heterozygous (Clcn3 +/-) and wild-type (Clcn3 +/+ ) littermates were used to test whether activation of VRCCs contributes to cardioprotection in early and/or second-window IPC. Targeted disruption of ClC-3 gene caused a decrease in the body weight but no changes in heart/body weight ratio. Telemetry ECG and echocardiography revealed no differences in ECG and cardiac function under resting conditions among all groups. Under treadmill stress (10 m/min for 10 min), the Clcn3 -/-mice had significant slower heart rate (648±12 bpm) than Clcn3 
Introduction
Ischemic preconditioning (IPC) is a phenomenon in which brief episodes of ischemia dramatically reduce myocardial infarction caused by a subsequent sustained ischemia [1] . IPC has an early phase (lasting 1-2 hours) 1266 and a late phase or "second-window" (lasting 24-72 hours) of protection [2] . The signaling pathways involved in both early IPC (eIPC) and second-window IPC (swIPC) have been the subjects of intensive studies in the last 25 years [3] [4] [5] [6] .
Ischemia causes myocardial damage and leads to infarction through necrosis and programmed cell death (apoptosis) [6, 7] . Recent studies in cardiac and noncardiac cells have demonstrated that both the necrotic cell volume increase (NVI) and the apoptotic cell volume decrease (AVD) are closely regulated by the volume-regulated chloride (Cl -) channels (VRCCs) or the cell swelling-activated Cl -current (I Cl,swell ), [8] [9] [10] suggesting that VRCCs may be intimately linked to IPC through regulation of cell volume homeostasis and thus necrotic and apoptotic events. The first evidence that I Cl,swell was involved in IPC came from a study by Diaz et al., which demonstrated that Cl -channel blockers 5-nitro-2-(3-phenylpropyl-amino) benzoic acid (NPPB) and indanyloxyacetic acid 94 (IAA-94) not only blocked the hypo-osmotic cell swelling induced current but also prevented the protection of isolated rabbit heart by IPC and hypo-osmotic stress [11] . Later studies from the same group provided further evidence to support the notion that I Cl.swell may be an important end-effector in IPC [12, 13] and it was believed that enhanced cell volume regulation may be a key mechanism for IPC protection [14] . These observations by Diaz et al., however, were seriously questioned by Heusch et al. [15, 16] . In an attempt to further confirm the effects of the same Cl -channel blockers on both Cl -channel activity in isolated ventricular myocytes and cardioprotection by IPC in isolated perfused rabbit heart, Heusch et al. found that the channel-blocking concentrations of both NPPB and IAA-94 were toxic in isolated perfused rabbit hearts, as evidenced by cessation of cardiac contraction and massive infarction, neither agent could be tested against IPC's anti-infarct effect [16] . The doses used in the report of Diaz et al. [11] did not affect coronary flow, heart rate and developed pressure, and also failed to prevent the infarct size reduction of IPC [16] . Similar results were obtained with an additional VRCCs blocker, 4, 4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS) [16] . At this point, therefore, at least two important questions remain unanswered: 1) whether VRCCs play a causal role in IPC protection; 2) whether VRCCs are involved in eIPC or swIPC [2] if activation of I Cl.swell is important in IPC protection.
The effort to confirm the causal role of VRCCs in IPC has been hampered by the fact that the currently available Cl -channel blockers lack specificity to any particular subgroup of Cl -channels that are concomitantly expressed in the same cardiac cell [11, 13, 15, 16] . Recently, a great deal of experimental evidence from many laboratories strongly supports that ClC-3, a member of the ClC voltage-gated Cl -channel superfamily, may be responsible for a key component of the native I Cl,swell in cardiac myocytes and many other tissues [8, [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] . Many of these published studies also link ClC-3 to cell volume regulation and apoptosis, [8, 17, [21] [22] [23] [24] [25] [26] [27] [28] further reinforcing a potential role of ClC-3 in IPC. Using gene targeting technique to specifically inactivate ClC-3 gene expression in the mouse provides a unique and powerful approach to directly address the question whether VRCCs play a role in both eIPC and swIPC. In this study, therefore, we applied both in vitro IPC of isolated working heart [31] and in vivo mouse eIPC and swIPC model [2] to a ClC-3 knockout (ClCn3 -/-) murine line [26, 32] a Isolated Langendorff and working heart preparations Cardiac hemodynamic parameters were recorded from isolated Langendorff and working heart preparations continuously during the experiment and analyzed off-line by HSE data acquisition system (HSE HAEMODYN, Harvard Apparatus) as described previously [31, 33] . Briefly, hearts were removed rapidly from mice anesthetized with pentobarbital sodium (50 mg/ kg, intraperitoneal injection). The aorta was cannulated with a cannula connected to the HSE isolated heart perfusion system (Model IH-1, Harvard Apparatus, Inc. Halliston, MA). Retrograde (Langendorff) perfusion was started instantly with modified Krebs-Henseleit buffer, which contained (in mmol/L): NaCl 118.0, KCl 4.7, CaCl 2 2.5, MgSO 4 1.2, KH 2 PO 4 1.2, NaHCO 3 25.0, pyruvate 2.0, glucose 11.0, EDTA-Na 2 0.5. Buffer was continuously bubbled with 95% O 2 and 5% CO 2 (pH 7.4, 37 o C) throughout the perfusion period. The left atrium was then cannulated and the hearts were perfused antegradely through the atrial cannula (working-heart mode, afterload 60 mmHg, preload 10 mmHg). Left ventricular pressure (LVP), left ventricular developed pressure (LVDP), and left ventricular end-diastolic pressure (LVEDP) were measured by a Millar tip catheter (1.4/0.8F pressure transducer, Millar) inserted into the left ventricular cavity through aorta or an open-ended PE-50 polyethylene cannula (O.D.=0.965 mm) inserted into the left ventricular cavity through the apex. Measurements of functional performance (aortic pressure, LVP, LVEDP, LVDP, first derivative of left ventricular developed pressure ±dP/dt and heart rate) were recorded continuously during the experiment and analyzed off-line by HSE data acquisition system. Cardiac output (CO) was calculated as the sum of coronary flow (CF) and aortic outflow collected during perfusion.
Assessment of tissue injury and viability
Total global ischemia by clamping both atrial inflow and aortic outflow was used for induction of sustained ischemia as well as for IPC. Myocardial tissue injury was determined by measuring infarct size using TTC staining as described previously [31, 33] . At the end of the experimental protocols, the hearts were perfused in the Langendorff mode for an additional 80 min and then frozen at -80 o C, transversely cut intõ 600 µm slices and stained with 1% triphenyl tetrazolium chloride (TTC) in phosphate buffer (pH 7.4) at 37 o C for 15 min. After fixation in 10% neutral buffered formaldehyde overnight, the slices were scanned and saved as JPEG files. The viable myocardium stained deep red and necrotic tissues remained pale. The entire risk area (the sum of total ventricular area minus cavities) was calculated in pixels using computer software (SimplePCI, Compix, Inc, Cranberry Township, PA) and infarct areas were compared to the entire area at risk in a gray scale fashion [31, 33] .
Caspase-3 measurement
The activated caspase-3 in the heart was measured using anti-active caspase 3 polyclonal antibody (ab13847, Abcam) and sodium dodecyl sulfate/polyacrylamide gel electrophoresis (SDS-PAGE) and immuno-blotting as described previously. At the end of protocol, ventricles of the heart were frozen in liquid nitrogen and the total protein from the ventricles was isolated, and resolved in 1X RIPA buffer (1% Triton X-100, 50 mM NaCl, 10 mM NaF, 1 mM Na 3 VO 4 , 5 mM EDTA, 10 mM Tris pH 7.6, 2 mM PMSF). Protein solution was mixed at 3:1 with 4 X Laemmli sample buffer (Bio-Rad) and incubated at 95°C for 5 min. The proteins were then fractionated by SDS-PAGE and electrotransferred to a nitrocellulose membrane. After washing, the membrane was blocked with odyssey blocking buffer (LI-COR) for 1 hr at RT. The membrane was then incubated overnight in the primary rabbit anti-active Caspase 3 polyclonal antibody (ab13847,abcam) at 4°C in the blocking buffer. After washing, the blots were incubated with secondary goat antirabbit 680 antibody (Li-Cor) (1:100,000) and imaged using the with Odyssey infrared imaging system and analyzed with Odyssey software (V1.2, LI-COR). GAPDH (glyceraldehyde-3-phosphate dehydrogenase) was used as the internal control.
Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay
In order to identify apoptotic cells containing DNA fragments, the tissue samples (serial 8 µm cryosections) were labeled by immunohistochemical staining using terminal deoxynucleotidyl transferase (TdT) and fluorescein conjugated nucleotides with the in situ cell death detection kit (Roche Applied Science) as described in the manufacturer's instructions. Negative control sections were prepared without the TdT enzyme and continuing with the staining. Labelled nuclei were identified from the negative nuclei counterstained by propidium iodide (PI) (Vector Laboratories, Inc. Burlingame, CA) and counted after being photographed under a fluorescence microscope at 40x magnification. The percentage of TUNEL positive nuclei (expressed as % of positive nuclei/all nuclei) was determined by counting the PI labelled nuclei and TUNEL positive nuclei present in the endocardium.
Cell volume measurement LV myocytes were isolated from adult (8-weeks) Clcn3
and Clcn3 -/-hearts using methods as described previously [34, 35] . After the enzyme treatment, the myocytes were dissociated and stored for 30 min in a modified KB solution [35, 36] containing (mmol/L): 70 potassium glutamate, 20 KCl, 1 MgCl 2 , 10 KH 2 PO 4 , 10 taurine, 10 EGTA, 10 glucose, 10 β-hydroxybutric acid, 10 Hepes, and 1mg/mL bovine albumin; pH 7.2 with KOH; 300 mOsm/kg with mannitol. Then 4 ml of the myocytes were transferred to a tube and 2 nL/mL of Di-8-ANEPPS (Molecular Probes, Invitrogen) were added. The myocytes were incubated in dark at room temperature (22-24 o C) for 30 min. Within the same day of isolation and treatment with Di-8-ANEPPS the myocytes were examined under fluorescent microscope for the measurement of cell volume changes under isotonic and hypotonic conditions. All cells studied were rod shaped, exhibited clear cross-striations, and lacked any visible blebs under isotonic conditions. Viable ventricular myocytes were stained red by Di-8. Hypotonic (230 mOsm/kg H 2 O, measured by freezingpoint depression) bath solutions contained (mmol/L) NaCl 100, MgCl 2 1, CaCl 2 1, BaCl 2 2, NaH 2 PO 4 0.33, CsCl 10, HEPES 10, glucose 5.5, pH 7.4. The isotonic and hypertonic bath solutions were the same as the hypotonic solution except the osmolarity was adjusted to 300 mOsm/kg H 2 O and 360
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Cell Physiol Biochem 2011;28:1265-1278 mOsm/kg H 2 O by adding mannitol. Cells were photographed under microscope (10x) every min while they were perfused with isotonic solution for 5 min and then with hypotonic solutions for 20 min. Cell dimensions (length and width) were measured with SimplePCI (Compix Inc., Cranberry Township, PA, USA). The cell volume (V) was estimated with assumed right cylindrical geometry according to the following equation:
, where V, L, and W are cell volume, length, and width, respectively [34, 37] . Experiments were conducted at room temperature (22°C to 24°C).
Radiotelemetry electrocardiography (ECG) recording system
During the various protocols of this study, ECG, heart rate (HR), activity, and body temperature were measured, collected and stored to hard disk of an IBM-compatible computer using the Data Sciences International radiotelemetry data acquisition system (Dataquest A.R.T. version 2.2, Data Sciences International, St Paul, MN). The mice were anesthetized with sodium pentobarbital (50~100 mg/kg, ip) and an incision (1.5 cm) was made along the midline immediately caudal to the xyphoid space for the subcutaneous placement of the body of the implantable transmitter (ETA-F20). The two insulated stainless-steel biopotential leads (0.5 mm diameter) of the transmitter were cut to the appropriate length and placed subcutaneously into the small incisions (0.5 cm) in the lead II configuration (negative lead to the right shoulder and the positive lead to the left of the xyphoid space and caudal to the rib cage). The device was included in the closing suture (4-0 non-absorbable) to prevent displacement. The mice were allowed to recover on a heating pad for 24hr. Measurements were taken every two hours for 20 seconds for up to five weeks. ECG data analyses were performed off-line using Physiostat ECG analysis software, version 3.1 (Data Sciences International). The QT interval was corrected for heart rate (QTc) using the following formula: QTc =QT/(RR/100) 1/2 as previously described [38] .
Treadmill Exercise Regimen
The animals in all groups were trained twice a week on rodent Treadmill Simplex II (Columbus Instruments, Columbus, Ohio) for 2 weeks before the implantation of the telemetry probe. The exercise regimen started 2 days (48 hrs) after surgery. The mice were allowed to acclimate to the treadmill (0-2 m/min) for 10 min prior to each trial. The mice were run at a speed of 5 m/ min for 10 min followed by 10 m/min for 10 min finishing with 15 m/min for 10 minutes. ECG was monitored with the telemetry system every two hours for 10 minutes at rest and continually during the treadmill exercise test.
Echocardiography
Transthoracic M-mode echocardiogram was used to assess left ventricle (LV) performance before and after IPC protocols using a GE Vingmed System Five Ultrasound, EchoPAC software version 6.2 with a 12 MHz transducer (GE Vingmed Ultrasound A/S, Horten, Norway). The mice were anesthetized with sodium pentobarbital (~25 mg/kg, ip). The dose of the anesthetics was chosen to maintain a heart rate at >600 beat-per-minute (bpm). After a good-quality two-dimensional image was obtained M-mode images of the left ventricle were recorded. All measurements were performed using the leading edge-to-leading edge convention adopted by the American Society of Echocardiography [39] . End-diastolic (ed) volume and end-systolic (es) volume were calculated for the fol- 
In vivo IPC experimental protocols Clcn3
, and Clcn3 -/-mice were randomly divided into eight early IPC (eIPC) and second-window IPC (swIPC) groups with various experimental protocols as described in details in the Results section. The mice were anesthetized with sodium pentobarbital (50 mg/kg, ip). Additional doses of pentobarbital were administered during the protocol as required to maintain anesthesia (up to a maximum total dose of 100 mg/kg, ip). The animals were intubated and ventilated with room air (approximately 21% oxygen with a tidal volume of 200 µl at a rate of 200 breaths/min), using a MiniVent rodent ventilator (Model 845, Hugo Sachs Elektronik, March Hugstettn, Germany). Body temperature was controlled through a heating pad, to maintain at ~37°C. Surface 12-lead ECG was recorded throughout the experiments on a Gould ACQ-7700 recorder (Gould Instrument Systems, Valley View, OH). A left thoracotomy was performed, the heart exposed, and the pericardium was removed from the left ventricle. The left anterior descending (LAD) coronary artery 2~3 mm from the tip of the left atrium was occluded with a prolene 8.0-silk suture. Successful coronary occlusion was verified by the development of a pale color in the distal myocardium through the use of a Surgical Microscope system (Applied Fiberoptics, Southbride, Massachusetts) and by S-T segment elevation and QRS widening on the ECG. Blood flow was restored by releasing the ligature. Successful reperfusion was confirmed when the bright red color of the left ventricle and the ECG returned to normal. The chest was closed and the mice were removed from the ventilator and allowed to recover on the heating pad, or sacrificed prior to removal from the ventilator depending on the IPC protocols (see below).
The experimental protocols for in vivo eIPC and swIPC models are described as follows (see also description in the corresponding figures): 1) eIPC (see 
Measurement of the myocardial infarction size
At the end of each protocol, 1.0 ml of 1% 2,3,5-triphenyltetrazolium chloride (TTC) solution (0.15M triss buffer, pH 7.8, at 4ºC) was injected as a bolus via the aorta into the left ventricular chamber. The coronary artery was reoccluded, and 0.2 ml of a 5% phthalol dye solution was then injected as a bolus via the aorta into the left ventricular chamber. The heart was then removed and the LV isolated. The weight of whole heart and the LV were measured. The isolated LV was placed into the -80º freezer for one hour. The LV was cut transversely into five slices from base to apex, and stored in 37% formaldehyde for 24hrs. Color digital images of both sides of each slice were obtained with a Sony DSC-F707 digital camera (Sony, Minokamo, Japan). The area under risk (tissue unstained by phthalol dye) and the infarct size (white tissue unstained by TTC) of the LV were outlined on each color image and quantified by a blinded observer using the image processing and analysis (IPA) module of Simple PCI image analysis software (Compic, Inc., USA) [31] . The percent infarction was calculated for each slice, and reported as the percent of infarct (white) tissue divided by the total area under risk (white and red).
Statistical Analysis
All group data is presented as mean±SEM. Statistical comparisons were performed either by Student's t test when only two groups were compared or by multiple analysis of variance (MANOVA) with Scheffé contrasts for group data. A 2-tailed probability value of P=0.05 was considered statistically significant. 
Results

Cardiovascular Phenotypes of Clcn3
, and Clcn3
-/-mice before the application of experimental surgery protocols. To eliminate the influence of reduction in the heart rate on cardiac performance under anesthetized status a small dose of sodium pentobarbital (~25 mg/kg, ip) was used to maintain the heart rate at ~600 bpm during recordings. Evaluation of systolic and diastolic LV wall thickness (IVS and LVPW), chamber dimension (LVID), and contractile function (LVEF and %FS) revealed no statistically significant differences between agematched Clcn3
, and Clcn3 -/-mice (see Table 1) .
A radiotelemetry system was used to continuously monitor the ECG, body temperature and activity of agematched Clcn3
, and Clcn3 -/-mice were under conscious conditions. No significant differences in HR, PQ, QRS, QT, or ST intervals on a standard lead II ECG were found at rest in these littermates (see Table  2 ), although the Clcn3 Table 2) .
Effect of targeted inactivation of ClC-3 gene on IPC in isolated working heart
Previous studies in the isolated rabbit heart showed controversial results on the role of VRCCs in IPC when using Cl -channel blockers [11, 16] . So, it is important to test whether IPC protect the heart from ischemia and reperfusion damage in the isolated Clcn3 -/-heart. Agematched male Clcn3 +/+ and Clcn3 -/-mice were randomly divided into two groups with the experimental protocols as described in Figure 1A to examine the effect of IPC on ischemia-induced myocardial infarct size. As shown in Figure 1B , IPC caused a significant recovery of the heart function in all three groups of age-matched mice, suggesting targeted inactivation of the ClC-3 gene failed to prevent IPC in isolated mouse heart.
Effect of targeted inactivation of ClC-3 gene on apoptosis
It has been demonstrated previously that apoptosis and necrosis are the major cell death pathways involved in I/R injury and myocardial infarction and that both IPC can reduce the I/R-induced apoptosis [6, 7] . To test whether activation of ClC-3 Cl -channels is important in the IPC-mediated inhibition of apoptosis, isolated Langendorff and working heart preparations of ex vivo IPC models were applied to age-matched male Clcn3 (Fig. 1C) , indicating that the IPCinduced inhibition of apoptosis in these hearts was not affected by knockout of ClC-3.
To further confirm the observations on the effects of ClC-3 knockout on the apoptosis of cardiac myocytes TUNEL assays were performed to detect apoptotic cells under I/R and IPC conditions. Figure 2A shows a representative image of TUNEL assays in mouse heart sections. In these studies, the reperfusion time was increased to >360 min to allow DNA damage to develop. In the control hearts not subject to global I/R, 420 min of perfusion caused the development of some TUNEL-positive (TN-P) nuclei in the epicardium, but none was detected in deeper layers of the myocardium (data not show). I/R caused 17.8±4.9% (n=6) and 28 (Fig. 2B) . These results further support ClC-3 may not be very important for the IPC-mediated inhibition of apoptosis in the heart.
To further determine whether ClC-3 encoded VRCCs play any functional role in IPC, we applied the in vivo eIPC and swIPC models, which are considered gold-standard for IPC, to the Clcn3 
, and Clcn3
-/-mice were randomly divided into four eIPC groups with the experimental protocols as described in Figure 3A . A surface standard lead II ECG was recorded throughout the surgery process to assess successful occlusion and reperfusion of the LAD coronary artery. M-mode echocardiogram was used to estimate the changes in cardiac function after surgery on Clcn3
, and Clcn3 -/-mice. As shown in Figure 3B , prolonged ischemia and reperfusion caused a significant decrease in cardiac function as estimated by LVEF while eIPC significantly protected the cardiac function from prolonged ischemia/reperfusion damage with a significantly blunted decrease in LVEF compared to the control groups in all Clcn3 (Fig. 3C) . These results indicate that targeted inactivation of ClC-3 gene failed to affect the cardioprotective effect of eIPC on mouse heart, suggesting that ClC-3 encoded VRCCs may play little role in the eIPC cadioprotection. mice, the reduction of LVEF and FS was significantly less than in the control groups, suggesting a protection of the cardiac function of these mice by swIPC against ischemia and reperfusion. In the swIPC group of Clcn3 -/-mice, however, no significant difference was observed in the reduction in LVEF and %FS compared to the control group after swIPC (Fig.  4B) . Similarly, swIPC significantly reduced myocardial infarction in Clcn3 (Fig. 4C) . These results indicate that targeted inactivation of ClC-3 gene abolished the cardioprotective effect of swIPC on mouse heart and suggest that ClC-3 encoded VRCCs may play an important role in swIPC.
The effect of targeted inactivation of
The effect of targeted inactivation of ClC-3 gene on cell volume regulation
Ischemia and reperfusion cause myocardium infarction through necrosis and apoptosis [6, 7, 40] . Irreversible isosmotic cell swelling or necrotic volume increase (NVI) due to ATP depletion under conditions of ischemia or hypoxia may cause cell rupture, i.e., necrotic cell death. On the other hand, isosmotic cell shrinkage or apoptotic volume decrease (AVD) is an integral part of apoptosis. Both NVI and AVD have been found to be closely regulated by VRCCs [8] [9] [10] and ClC-3 [8, 17, [21] [22] [23] [24] [25] [26] [27] [28] . Therefore, it is important to examine whether knockout of ClC-3 gene causes any changes in cell volume regulation. As shown in Figure 5 , exposure of the ventricular myocytes isolated from Clcn3 +/+ mouse heart to hypotonic superfusion solution caused a quick increase in cell volume (solid circles), which reached a plateau within 10 min and then began to decrease (RVD) back to the normal cell volume as in the isotonic solutions after approximately 15 min in the continued presence of hypotonic solution. Exposure of these cells to a hypertonic superfusion solution caused further decrease in cell volume (shrinkage). In ventricular myocytes from Clcn3 -/-mice, cell volume also increased soon after exposure to hypotonic superfusion solutions but the maximum increase in cell volume (158.3±11.8%, n=4) was significantly larger than that of Clcn3 +/+ mice (121.6±9.6%, n=5, P<0.05) at a faster rate (solid squares). Although an initiation of RVD also began to occur after 10 min in the hypotonic superfusion solution the RVD never reached to the normal cell volume and a second increase in cell volume quickly occurred and all cells ruptured due to an excessive increase in cell volume in the hypotonic solutions. These data suggest that one functional consequence of ClC-3 knockout in the heart is an impaired RVD in individual myocytes.
Discussion
In this study we applied well-established in vivo eIPC and swIPC models to a Clcn3 -/-murine line to directly 
Phenotype of Clcn3
-/-mice Targeted disruption of ClC-3 gene causes extensive hippocampal neurodegeneration and retina malformation resulting in blindness and lead to a proportional decrease in body weight through an unknown mechanism [32, 40, 41] . Therefore, before the application of the IPC models to the Clcn3 -/-mice, we carefully examined the cardiovascular phenotype of these mice using echocardiography and telemetry ECG measurements. To eliminate the possible effect of anesthesia-induced changes in heart rate on cardiac performance the echocardiography recordings were made at similar heart rate. In addition, telemetry was used to assess the cardiovascular phenotype of the mice in non-anesthetized and unrestricted conditions. Under resting conditions no significant differences were observed in heart rate, PQ, QRS, QT, ST intervals or body temperature in age-matched Clcn3 -/-mice and their heterozygous or wild type littermates. These results indicate that ClC-3 deletion does not affect the basic electrophysiological and hemodynamic performance of the mouse. Therefore, ClC-3 does not appear to contribute significantly to cardiovascular function at rest. This is consistent with the very limited basal VRCC activity under physiological conditions. VRCCs or ClC-3 channels may be activated, however, under stressed conditions [21] [22] [23] 42] . Cardiovascular stress in response to treadmill exercise is frequently used to detect cardiac abnormalities that are not readily apparent at rest. Therefore, we combined the telemetric technique with a treadmill exercise protocol to quantify the electrophysiological performance of Clcn3 -/-mice under stress in a nonrestrained manner [43] . While exercise increased HR and decreased QRS and QT intervals to identical levels in both Clcn3 +/+ and Clcn3 +/-mice the same exercise training increased HR to lesser extent and failed to change QRS and QT intervals in Clcn3 -/-mice. These results suggest that ClC-3 channels play a much more prominent role in the regulation of cardiac electric activity under stressed conditions than at rest. Although activation of VRCCs will contribute both inward (Cl -efflux) and outward (Cl -influx) currents during the normal cardiac cycle it will have more significant effects at positive potentials to cause a repolarization and shortening of the action potential duration (APD) compared with smaller depolarizing effects at negative potentials near the resting membrane potential due to the stronger outwardly rectifying property of the ClC-3 currents [22, 42, 44] . A faster repolarization phase and shorter APD caused by activation of ClC-3 channels may explain why QRS and QT intervals were shortened in Clcn3 mice may be, at least in part, due to the decrease in the inward depolarizing current and also the outward repolarizing current. Since I Cl.swell was also found in sino-atrial (SA) nodal cells, ClC-3 channels may play a significant role in the pacemaker function in these cells [42] . Disruption of ClC-3 in the SA nodal cells may therefore also lead to the failure to respond to positive chronotropic effect of exercise in Clcn3 -/-mice. These data provide the first in vivo experimental evidence for the functional role of VRCCs in cardiac electrophysiology and hemodynamics.
Functional role of VRCCs in eIPC and swIPC
Using the in vivo models of eIPC and swIPC on genetically engineered mice and combined echocardiography and histological analyses we found in this study that ClC-3 encoded VRCCs may play an important cardioprotective role in swIPC but they may not contribute significantly to the eIPC protection. These findings are consistent in general with previous studies in terms of that VRCCs play a cardioprotective role in IPC. Diaz et al. observed that several Cl -channel blockers abolished IPC protection caused by hypoosmotic stress, ischemia/reperfusion, and pharmacological agents in isolated rabbit heart, implicating a functional role of VRCCs in eIPC [11] [12] [13] [15, 16] . In the mouse in vivo IPC model, we found that targeted disruption of ClC-3, which significantly altered endogenous VRCCs in mouse heart [35] , did not affect the cardioprotective effect of eIPC. Our results, therefore, are in agreement with Heusch et al. and do not support a causal role of VRCCs in eIPC either. However, it is clear that the swIPC-induced cardioprotection was abolished by ClC-3 disruption, and thus our results strongly support the notion of that VRCCs are important mediators in IPC. Some of the discrepancies between our results and those of Diaz et al. and Heusch et al. may be due to the differences in species (mouse vs rabbit) and IPC models (in vivo vs in vitro) [11-13, 15, 16] .
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Functional role of VRCCs in cell volume regulation and cell death
Recent studies have shown that IPC protects myocardium against infarction through inhibition of apoptosis and limitation of necrosis [6, 7, 40, 45] . But it remains unclear how much the contribution of each of the two forms of cell death to ischemia/reperfusion-induced myocardial damage and infarction and whether the beneficial effects of eIPC and swIPC are mediated by similar or different signal transduction pathways involved in necrosis or apoptosis. Necrotic cell death, i.e., cell rupture is paralleled by irreversible isosmotic cell swelling or NVI, which is caused by ATP depletion under conditions of injury, hypoxia, ischaemia, or acidosis. Isosmotic cell shrinkage or apoptotic cell volume decrease (AVD) is an integral part of apoptosis. Both NVI and AVD have been found to be closely regulated by VRCCs. In the face of anisotonic perturbations, the ability of the cell to effectively control its internal environment and cell volume by mechanisms of RVD or RVI after osmotic swelling or shrinkage, respectively, is critical for cell survival under pathophysiological conditions. Dysfunction of RVD or RVI due to impairment of VRCC function causes persistent cell swelling or shrinkage and ultimately cell death through NVI or AVD, respectively. When the cell volume regulatory mechanism is altered, stress such as ischemia/reperfusion would lead to enhanced myocardial infarction. A close link between apoptosis and the activity of native I Cl,swell and the expression of ClC-3 protein has been established previously in both cardiac and non-cardiac cells and tissues [8-10, 25, 46] . In a recent study, for example, Lemonnier and colleagues [9, 25] . This was accompanied by substantial up-regulation of ClC-3 protein. Furthermore, treatment of wild-type LNCaP cells with epidermal growth factor, which promotes cell proliferation, resulted in the enhancement of endogenous Bcl-2 expression and associated increases in ClC-3 levels and I Cl,swell magnitude. ClC-3-specific antibody suppressed I Cl,swell in the wild-type and Bcl-2-overexpressing LNCaP cells. Therefore, Bcl-2-induced up-regulation of I Cl,swell , caused by enhanced expression of ClC-3 and weaker negative control from SOCtransported Ca
2+
, may strengthen the ability of the cells to handle cell volume perturbations and thereby promote their survival and diminish their proapoptotic potential. On the other hand, in an in vivo rat heart global I/R model, Mizoguchi et al. found that intravenous administration of Cl -channel blockers DIDS and NPPB were as potent as a broad-spectrum caspase inhibitor, benzoyloxycarbonylAsp-CH2OC(O)-2,6-dichlorobenzene (Z-Asp-DCB), in reducing myocardial DNA fragmentation, caspase activation, and improving cardiac contractile function after acute ischemia and 24-hr in vivo reperfusion [46] . These results suggest that inhibition of VRCCs is also effective for preventing apoptosis and elevation of caspase-3 activity during acute cardiac I/R injury. In eIPC, activation of PKC may inhibit the activation of VRCCs and thus prevent cell death. This may explain why ClC-3 deletion actually did not prevent the cardioprotective effect of eIPC. In swIPC, cell swelling-induced increase in VRCCs' function and upregulation of ClC-3 expression would strengthen the RVD mechanism and prevent the NVI process of cardiac cells. Activation of VRCCs would increase the apoptotic resistant of the cell in the face of further ischemic perturbations. If brief periods of ischemia and reperfusion cause the upregulation of ClC-3 expression the effects of its anti-apoptotic properties would require time to manifest. This may explain why the late phase of IPC is affected but not the early phase of IPC in ClC-3 knockout mice. The differential effects of ClC-3 disruption on eIPC and swIPC may reflect the involvement of VRCCs in different mechanisms for the cardioprotection in eIPC and
